Phenominer Database Results (21 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
DA.PVG.1AV1-(D4Rat23-D4Rat108)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 31 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 10 22.6 d in vivo visual assessment 0.0 subcutaneous injection 31 days from 8 to 31days days 69396 892
DA.PVG.1AV1-(D4Got60-D4Kini1)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 38 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 11 17.6 d in vivo visual assessment 0.0 subcutaneous injection 38 days from 8 to 38days 69408 892
DA/ZtmKini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 28 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 21 11.5 d in vivo visual assessment 0.0 subcutaneous injection 28 days from 8 to 28 days 69419 892
DA.PVG.1AV1-(D4Rat23-D4Rat108)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 10 2.7 d in vivo visual assessment 0.0 subcutaneous injection 34 days from 8 to 34 days 69428 892
DA/ZtmKini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 31 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 18 14.3 d in vivo visual assessment 0.0 subcutaneous injection 31 days from 8 to 31 days days 69392 892
DA.PVG.1AV1-(D4Rat23-D4Mit12)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 18 6.0 d in vivo visual assessment 0.0 subcutaneous injection 34 days from 8 to 34 days 69430 892
DA.PVG.1AV1-(D4Rat103-D4Mit12)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 9 5.9 d in vivo visual assessment 0.0 subcutaneous injection 34 days from 8 to 34 days 69432 892
DA.PVG.1AV1-(D4Rat231-D4Mit12)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 14 7.8 d in vivo visual assessment 0.0 subcutaneous injection 34 days from 8 to 34 days 69434 892
DA/ZtmKini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 37 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 28 10.7 d in vivo visual assessment 0.0 subcutaneous injection 37 days from 8 to 37 days days 69381 892
DA.PVG.1AV1-(D4Got211-D4Mit12)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 16 4.9 d in vivo visual assessment 0.0 subcutaneous injection 40 days from 8 to 40 days days 69389 892
DA.PVG.1AV1-(D4Rat23-D4Rat108)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 7 22.4 d in vivo visual assessment 0.0 subcutaneous injection 40 days from 8 to 40 days 69414 892
DA.PVG.1AV1-(D4Rat103-D4Mit12)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 28 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 19 11.2 d in vivo visual assessment 0.0 subcutaneous injection 28 days from 8 to 28 days 69421 892
DA/ZtmKini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 17 9.0 d in vivo visual assessment 0.0 subcutaneous injection 34 days from 8 to 34 days 69425 892
DA/ZtmKini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 16 6.8 d in vivo visual assessment 0.0 subcutaneous injection 40 days from 8 to 40 days days 69386 892
DA/ZtmKini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 38 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 18 20.9 d in vivo visual assessment 0.0 subcutaneous injection 38 days from 8 to 38 days days 69393 892
DA.PVG.1AV1-(D4Got211-D4Mit12)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 31 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 19 11.8 d in vivo visual assessment 0.0 subcutaneous injection 31 days from 8 to 31days days 69399 892
DA.PVG.1AV1-(D4Rat23-D4Mit12)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 14 18.4 d in vivo visual assessment 0.0 subcutaneous injection 40 days from 8 to 40 days 69417 892
DA.PVG.1AV1-(D4Got60-D4Kini1)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 38 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 24 5.5 d in vivo visual assessment 0.0 subcutaneous injection 37 days from 8 to38 days days 69383 892
DA.PVG.1AV1-(D4Got60-D4Kini1)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 6 7.5 d in vivo visual assessment 0.0 subcutaneous injection 34 days from 8 to 34 days 69437 892
DA/ZtmKini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 10 23.8 d in vivo visual assessment 0.0 subcutaneous injection 40 days from 8 to 40 days 69411 892
DA.PVG.1AV1-(D4Rat231-D4Mit12)/Kini experimental autoimmune encephalomyelitis duration myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 28 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female 0 days 21 13.3 d in vivo visual assessment 0.0 subcutaneous injection 28 days from 8 to 28 days 69423 892